Search - tctmd.com

Displaying 321 - 340 of 2042

Sort: Relevancy | Date

Presentation Complex Coronary Cases 2023

App Technology in Shock

Presenter: Annapoorna S. Kini

June 15, 2023

Presentation Complex Coronary Cases 2023

National Cardiogenic Shock Initiative

Presenter: William O’Neill

June 15, 2023

Presentation Complex Coronary Cases 2023

ACS and Antiplatelet Therapies2023

Presenter: Joseph M. Sweeny

June 14, 2023

Presentation EuroPCR 2023

Poor outcomes in occlusive ACS patients presenting without ST-elevation

Presenter: Robert Herman

May 19, 2023

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

Presentation Fellows 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 11, 2023

Presentation Fellows 2023

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: Nicholas Lembo

May 11, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation Miami Valves 2023

Step - By - Step Approach to Cardiogenic Shock

Presenter: William O’Neill

February 04, 2023

Presentation Miami Valves 2023

Management of high thrombotic burden in ACS

Presenter: Diego H. González-Bravo

February 04, 2023

Presentation Miami Valves 2023

SCD Prevention: Highlights of 35 years´ Research Collaboration Between Miami and Oulu Cardiac Research Teams

Presenter: Heikki V. Huikuri

February 03, 2023

Presentation TCT 2022

Con

Presenter: Nihar Desai

September 19, 2022

Presentation TCT 2022

Pro

Presenter: Babar Basir

September 19, 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From OCT Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presentation TCT 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presenter: Toshiro Shinke

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Presenter: Sanjit Jolly

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Presenter: William Fearon

September 19, 2022

Presentation TCT 2022

Short DAPT or De-Escalation After ACS

Presenter: Claudio Laudani

September 18, 2022

Presentation TCT 2022

Hemodynamic Support for High-Risk PCI in ACS

Presenter: Alaide Chieffo

September 17, 2022

Presentation TCT 2022

Management of No-Reflow in ACS

Presenter: Natalia Pinilla

September 17, 2022

Advertisement

App Technology in Shock

National Cardiogenic Shock Initiative

ACS and Antiplatelet Therapies2023

Poor outcomes in occlusive ACS patients presenting without ST-elevation

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

State-of-the-Art in NSTE-ACS: Management Strategies

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Step - By - Step Approach to Cardiogenic Shock

Management of high thrombotic burden in ACS

SCD Prevention: Highlights of 35 years´ Research Collaboration Between Miami and Oulu Cardiac Research Teams

Con

Pro

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

New and Emerging Pharmacology for ACS: Factor XI Inhibition

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Short DAPT or De-Escalation After ACS

Hemodynamic Support for High-Risk PCI in ACS

Management of No-Reflow in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content